• 

  December 2, 2024

  Carl Roth Partners with BIO INX to Advance 3D Bioprinting Accessibility

  R.D. Solorzano

• 

  November 27, 2024

  French Based Lattice Medical Wins Coveted US MedTech Innovator Mid-Stage Grand Prize

  R.D. Solorzano

• 

  November 26, 2024

  CELLINK’s Strategic Shift: Right-Sizing for Long-Term Profitability

  R.D. Solorzano

• 

  November 25, 2024

  Cellbricks Therapeutics Expands to the U.S., Launches Subsidiary in Cambridge, MA

  R.D. Solorzano

• 

  November 22, 2024

  BICO Divests Nanoscribe: A Strategic Shift Towards Life Sciences

  R.D. Solorzano

• 

  November 13, 2024

  Xolo Unveils Xell: An Affordable Volumetric Bioprinter for Labs

  R.D. Solorzano

• 

  October 23, 2024

  UpNano’s €7 Million Funding Fuels Expansion of 2 Photon Polymerization and Bioprinting Applications

  R.D. Solorzano

• 

  October 19, 2024

  Biological Lattice Industries Secures $1.8 Million Pre-Seed Funding to innovate with a new technology called melt electrowritten in combination with unique software

  R.D. Solorzano

• 

  August 10, 2023

  The DM, Stratasys, 3DS Merger Saga from the view of their Bioprinting Portfolios

  R.D. Solorzano

• 

  August 8, 2023

  The Buzz in the Markets about Bioprinting

  R.D. Solorzano